About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
Informations générales Entité de rattachement Le CEA est un acteur majeur de la recherche, au service des citoyens, de léconomie et de lEtat. Il apporte des solutions concrètes à leurs besoins dans quatre domaines principaux :
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
Job title : Scientist I Bioreactor Process Development, Pilot Location : Toulouse, France Type of contract : Permanent We’re excited to share this opportunity is part of the Sandoz acquisition of Just-Evotec Biologics in Toulouse. Through
Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast-growing start-up headquartered in Paris, incorporated in October
Who we are ? We are Pierre Fabre Laboratories, a global leader combining pharmaceutical expertise with dermo-cosmetics to support consumers and patients at every stage of their care journey. Our portfolio includes several medical franchises and
Lumos is a health and life-science AI evaluation company based in San Francisco. Our mission is to make health and life-science AI genuinely accurate and safe. We build the benchmarks, RL environments, and adversarial testing frameworks